Home›Articles›The Design Choice Behind Fruquintinib's SelectivityArticleThe Design Choice Behind Fruquintinib's SelectivityArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnFruquintinib, Drugs and Medicinal Substances Well-attested SourcesFruquintinib (Wikipedia)History and Pharmacology sectionsQuote, History and Pharmacology sectionsThe earlier generation small molecule VEGFR inhibitors, such as sunitinib, sorafenib, regorafenib and pazopanib suffer from poor kinome selectivity.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.